Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review
- PMID:22682429
- PMCID: PMC3405448
- DOI: 10.1186/1471-2261-12-41
Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review
Abstract
Background: There is increasing concern that prescription stimulants may be associated with adverse cardiovascular events such as stroke, myocardial infarction, and sudden death. Public health concerns are amplified by increasing use of prescription stimulants among adults.
Methods: The objective of this study was to conduct a systematic review of the evidence of an association between prescription stimulant use and adverse cardiovascular outcomes. PUBMED, MEDLINE, EMBASE and Google Scholar searches were conducted using key words related to these topics (MESH): ADHD; Adults; Amphetamine; Amphetamines; Arrhythmias, Cardiac; Cardiovascular Diseases; Cardiovascular System; Central Nervous Stimulants; Cerebrovascular; Cohort Studies; Case-control Studies; Death; Death, Sudden, Cardiac; Dextroamphetamine; Drug Toxicity; Methamphetamine; Methylphenidate; Myocardial Infarction; Stimulant; Stroke; Safety. Eligible studies were population-based studies of children, adolescents, or adults using prescription stimulant use as the independent variable and a hard cardiovascular outcome as the dependent variable.
Results: Ten population-based observational studies which evaluated prescription stimulant use with cardiovascular outcomes were reviewed. Six out of seven studies in children and adolescents did not show an association between stimulant use and adverse cardiovascular outcomes. In contrast, two out of three studies in adults found an association.
Conclusions: Findings of an association between prescription stimulant use and adverse cardiovascular outcomes are mixed. Studies of children and adolescents suggest that statistical power is limited in available study populations, and the absolute risk of an event is low. More suggestive of a safety signal, studies of adults found an increased risk for transient ischemic attack and sudden death/ventricular arrhythmia. Interpretation was limited due to differences in population, cardiovascular outcome selection/ascertainment, and methodology. Accounting for confounding and selection biases in these studies is of particular concern. Future studies should address this and other methodological issues.
Similar articles
- [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].Bange F, Le Heuzey MF, Acquaviva E, Delorme R, Mouren MC.Bange F, et al.Arch Pediatr. 2014 Jan;21(1):108-12. doi: 10.1016/j.arcped.2013.11.001. Epub 2013 Dec 3.Arch Pediatr. 2014.PMID:24309201French.
- Recommendation for Long-term Management of Adult Attention-Deficit/Hyperactivity Disorder in Military Populations, Veterans, and Dependents: A Narrative Review.Baughman DJ, Watson CM, Beich JW, Herboso MNJ, Cuttie LK, Marlyne AC.Baughman DJ, et al.Mil Med. 2024 May 18;189(5-6):e1343-e1352. doi: 10.1093/milmed/usad403.Mil Med. 2024.PMID:37878798Review.
- Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, Dittmann RW, Hollis C, Kovshoff H, McCarthy S, Nagy P, Sonuga-Barke E, Wong IC, Zuddas A, Rosenthal E, Buitelaar JK; ADDUCE consortium.Hennissen L, et al.CNS Drugs. 2017 Mar;31(3):199-215. doi: 10.1007/s40263-017-0410-7.CNS Drugs. 2017.PMID:28236285Free PMC article.Review.
- Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.Martinez-Raga J, Knecht C, Szerman N, Martinez MI.Martinez-Raga J, et al.CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9.CNS Drugs. 2013.PMID:23160939Review.
- Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder.Olfson M, Huang C, Gerhard T, Winterstein AG, Crystal S, Allison PD, Marcus SC.Olfson M, et al.J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):147-56. doi: 10.1016/j.jaac.2011.11.008. Epub 2011 Dec 20.J Am Acad Child Adolesc Psychiatry. 2012.PMID:22265361Free PMC article.
Cited by
- Effects of methylphenidate on blood pressure, QT-interval, and cardiac output in ADHD diagnosed children: A three months' follow-up study.Omidi N, Mojtaba Ghorashi S, Zahedi Tajrishi F, Effatpanah M, Khatami F, Rafie Khorgami M.Omidi N, et al.Int J Cardiol Heart Vasc. 2021 Jun 2;34:100805. doi: 10.1016/j.ijcha.2021.100805. eCollection 2021 Jun.Int J Cardiol Heart Vasc. 2021.PMID:34141860Free PMC article.
- Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults.Tadrous M, Shakeri A, Chu C, Watt J, Mamdani MM, Juurlink DN, Gomes T.Tadrous M, et al.JAMA Netw Open. 2021 Oct 1;4(10):e2130795. doi: 10.1001/jamanetworkopen.2021.30795.JAMA Netw Open. 2021.PMID:34694389Free PMC article.
- Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules.Wang Y, Yu M, Yan B, Martin P, Robertson B.Wang Y, et al.Drugs R D. 2019 Jun;19(2):167-175. doi: 10.1007/s40268-019-0267-y.Drugs R D. 2019.PMID:30911906Free PMC article.Clinical Trial.
- Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate.Stammschulte T, Pitzer M, Rascher W, Becker M, Pohlmann U, Ostermayer S, Kerst G.Stammschulte T, et al.Eur Child Adolesc Psychiatry. 2022 Jun;31(6):939-945. doi: 10.1007/s00787-021-01729-2. Epub 2021 Feb 3.Eur Child Adolesc Psychiatry. 2022.PMID:33537905
- Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder.Houghton R, de Vries F, Loss G.Houghton R, et al.CNS Drugs. 2020 Jan;34(1):93-101. doi: 10.1007/s40263-019-00686-4.CNS Drugs. 2020.PMID:31768949Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical